Bio Invitro Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 05-12-2024
- Paid Up Capital ₹ 0.20 M
as on 05-12-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -45.41%
(FY 2019)
- Profit 55.39%
(FY 2019)
- Ebitda 167.47%
(FY 2019)
- Net Worth -2.81%
(FY 2019)
- Total Assets -21.02%
(FY 2019)
About Bio Invitro Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Jyotsnaben Shah and Chaitali Shah serve as directors at the Company.
- CIN/LLPIN
U85110GJ2004PTC044628
- Company No.
044628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bio Invitro Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotsnaben Shah  | Director | 10-May-2005 | Current |
| Chaitali Shah | Director | 20-Aug-2004 | Current |
Financial Performance of Bio Invitro Diagnostics.
Bio Invitro Diagnostics Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 45.41% decrease. The company also saw a substantial improvement in profitability, with a 55.39% increase in profit. The company's net worth dipped by a decrease of 2.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Invitro Diagnostics?
In 2019, Bio Invitro Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arogyam Microcare Private LimitedActive 14 years 1 monthJyotsnaben Shah and Chaitali Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Invitro Diagnostics?
Unlock and access historical data on people associated with Bio Invitro Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Invitro Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Invitro Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
